Quantcast
Skip to content Skip to footer

Business trip: The new economy of therapeutic psychedelics

Matias Serebrinsky, co-founder and general partner at psychedelic treatment investment fund PsyMed Ventures, believes the next generation of psychedelic therapies offering greater efficacy without side-effects will redraw the battle lines in the war against mental illness

Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]